Okonechnikov, Konstantin
Joshi, Piyush https://orcid.org/0000-0002-5631-336X
Körber, Verena
Rademacher, Anne https://orcid.org/0000-0003-3054-3121
Bortolomeazzi, Michele https://orcid.org/0000-0001-5805-5774
Mallm, Jan-Philipp https://orcid.org/0000-0002-7059-4030
Vaillant, Jan https://orcid.org/0009-0003-6283-9581
da Silva, Patricia Benites Goncalves
Statz, Britta
Sepp, Mari https://orcid.org/0000-0003-1733-8385
Sarropoulos, Ioannis https://orcid.org/0000-0002-2242-0562
Yamada, Tetsuya
Wittmann, Andrea
Schramm, Kathrin
Blattner-Johnson, Mirjam
Fiesel, Petra
Jones, Barbara
Jäger, Natalie https://orcid.org/0000-0002-9589-7580
Milde, Till https://orcid.org/0000-0002-7267-1052
Pajtler, Kristian W. https://orcid.org/0000-0002-3562-6121
van Tilburg, Cornelis M. https://orcid.org/0000-0001-5274-910X
Witt, Olaf https://orcid.org/0000-0003-3918-9157
Bochennek, Konrad
Weber, Katharina Johanna
Nonnenmacher, Lisa
Reimann, Christian https://orcid.org/0009-0005-2487-4313
Ghasemi, David R. https://orcid.org/0000-0002-3844-9933
Schüller, Ulrich https://orcid.org/0000-0002-8731-1121
Mynarek, Martin https://orcid.org/0000-0003-3302-2719
Rutkowski, Stefan
Jones, David T. W. https://orcid.org/0000-0002-2036-5141
Korshunov, Andrey
Rippe, Karsten https://orcid.org/0000-0001-9951-9395
Westermann, Frank https://orcid.org/0000-0003-1584-3636
Thongjuea, Supat
Höfer, Thomas
Kaessmann, Henrik https://orcid.org/0000-0001-7563-839X
Kutscher, Lena M. https://orcid.org/0000-0002-1130-4582
Pfister, Stefan M. https://orcid.org/0000-0002-5447-5322
Article History
Received: 3 January 2024
Accepted: 3 April 2025
First Online: 7 May 2025
Competing interests
: C.M.v.T. participates on advisory boards for Alexion, Bayer and Novartis. The other authors declare no competing interests.